Medication Management Practices for Non-Communicable Diseases during the Second Wave of the COVID-19 Pandemic: A Snapshot of the European Situation

Author(s)

Kardas P1, van Boven JFM2, Wettermark B3, Menditto E4, Pinnock H5, Tsiligianni I6, Agh T7
1Medication Adherence Research Centre, Department of Family Medicine, Medical University of Lodz, Lodz, LD, Poland, 2University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy & Pharmacology, Groningen, Netherlands, 3Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden, 4CIRFF, Center of Phamacoeconomics and Drug utilization Research, University of Naples; Department of Pharmacy, Univeristy of Naples Federico II, Naples, Italy, 5Usher Institute, University of Edinburgh, Edinburgh, UK, 6Department of Social Medicine, School of Medicine, University of Crete, Crete, Greece, 7Syreon Research Institute, Budapest, Hungary

OBJECTIVES: The appropriate management of non-communicable diseases (NCDs) is particularly important during a pandemic; however, the intensive focus on COVID-19 prevention, and the lockdown and physical distancing restrictions affected NCD-related healthcare services adversely. We aimed to evaluate medication management practices for NCDs during the second wave of the COVID-19 pandemic across Europe and assess association with COVID-19 burden and country income.

METHODS: In December 2020, COST Action ENABLE (CA19132) conducted a cross-sectional, web-based survey in 38 European countries and Israel on available face-to-face and e-health medication management services in place for NCDs. COVID-19 burden was defined as the number of positive cases and deaths per 100,000 inhabitants; country income was assessed as gross domestic product per capita (GDP/capita) at purchasing power parity. Descriptive statistics, nonparametric tests and generalized linear models were applied in this analysis.

RESULTS: 53 experts (i.e., healthcare providers and academics with medical or pharmaceutical backgrounds) from 39 countries completed the survey. In 35 (90%) of countries face-to-face consultations were limited and this showed a positive association with the number of COVID-19 cases (p=0.03) and deaths (p=0.05). The mean (SD) number of available e-health services (including e-mail, online chat, phone, videoconference, electronic health record portal or other) was 3 (1.3) and this was positively associated with GDP/capita of countries (p=0.05). There was no further association between the evaluated variables.

CONCLUSIONS: Although COVID-19 limited the number of face-to-face appointments in NCD care, it accelerated e-health solutions. Reduction in face-to-face consultations was associated with greater burden of COVID-19; however, the uptake of e-health services was associated with higher country income. This suggests significant disparities in maintaining services for NCDs across Europe during the second wave of the pandemic.

Conference/Value in Health Info

2021-11, ISPOR Europe 2021, Copenhagen, Denmark

Value in Health, Volume 24, Issue 12, S2 (December 2021)

Code

POSB248

Topic

Health Policy & Regulatory, Health Service Delivery & Process of Care, Methodological & Statistical Research

Topic Subcategory

Disease Management, Health Disparities & Equity, Survey Methods

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×